...
首页> 外文期刊>Journal of Medicinal Chemistry >Design and Synthesis of 1?(3-(Dimethylamino)propyl)-1 -(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (Citalopram) Analogues as Novel Probes for the Serotonin Transporter S1 and S2 Binding Sites
【24h】

Design and Synthesis of 1?(3-(Dimethylamino)propyl)-1 -(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (Citalopram) Analogues as Novel Probes for the Serotonin Transporter S1 and S2 Binding Sites

机译:设计和合成1?(3-(二甲基氨基)丙基)-1-(4-氟苯基)-1,3-二氢异苯并呋喃-5-腈(西酞普兰)类似物作为血清素转运蛋白S1和S2结合位点的新型探针

获取原文
获取原文并翻译 | 示例

摘要

The serotonin transporter (SERT) is the primary target for antidepressant drugs. The existence of a high affinity primary orthosteric binding site (S1) and a low affinity secondary site (S2) has been described, and their relation to antidepressant pharmacology has been debated. Herein, structural modifications to the N, 4, 5, and 4′ positions of (±)citalopram (1) are reported. All of the analogues were SERT-selective and demonstrated that steric bulk was tolerated at the SERT S1 site, including two dimeric ligands (15 and 51). In addition, eight analogues were identified with similar potencies to S-1 for decreasing the dissociation of [~3H]S-1 from the S1 site via allosteric modulation at S2. Both dimeric compounds had similar affinities for the SERT S1 site (K_i = 19.7 and 30.2 nM, respectively), whereas only the N-substituted analogue, 51, was as effective as S-1 in allosterically modulating the binding of [~3H]S-1 via S2.
机译:血清素转运蛋白(SERT)是抗抑郁药的主要靶标。已经描述了高亲和力正构结合位点(S1)和低亲和力次级结合位点(S2)的存在,并且已经讨论了它们与抗抑郁药理学的关系。在此,报道了对(±)西酞普兰(1)的N,4、5和4'位置的结构修饰。所有类似物均具有SERT选择性,并证明在SERT S1位点可容忍空间位阻,包括两个二聚体配体(15和51)。另外,鉴定出八种类似物,具有与S-1相似的效力,可用于通过S2的变构调节来减少[〜3H] S-1从S1位点的解离。两种二聚体化合物对SERT S1位点的亲和力相似(分别为K_i = 19.7和30.2 nM),而只有N取代的类似物51在变构调节[〜3H] S的结合方面与S-1一样有效。通过S2 -1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号